Srivastava P C, Pickering M V, Allen L B, Streeter D G, Campbell M T, Witkowski J T, Sidwell R W, Robins R K
J Med Chem. 1977 Feb;20(2):256-62. doi: 10.1021/jm00212a014.
A general reaction of glycosyl cyanides with liquid hydrogen sulfide in the presence of 4-dimethylaminopyridine to provide the corresponding glycosylthiocarboxamides is described. These glycosylthiocarboxamides were utilized as the precursors for the synthesis of 2-D-ribofuranosylthiazole-4-carboxamide and 2-beta-D-ribofuranosylthiazole-5-carboxamide (23). The structural modification of 2-beta-D-ribofuranosylthiazole-4-carboxamide (12) into 2-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)thiazole-4-carboxamide (15), 2-beta-D-ribofuranosylthiazole-4-thiocarboxamide (17), and 2-(5-deoxy-beta-D-ribofuranosyl)thiazole-4-carboxamide (19) is also described. These thiazole nucleosides were tested for in vitro activity against type 1 herpes virus, type 3 parainfluenza virus, and type 13 rhinovirus and an in vivo experiment was run against parainfluenza virus. They were also evaluated as potential inhibitors of purine nucleotide biosynthesis. It was shown that the compounds (12 and 15) which possessed the most significant antiviral activity were also active inhibitors (40-70%) of guanine nucleotide biosynthesis.
描述了糖基氰化物在4-二甲基氨基吡啶存在下与液态硫化氢发生的一般反应,以提供相应的糖基硫代羧酰胺。这些糖基硫代羧酰胺被用作合成2-D-呋喃核糖基噻唑-4-甲酰胺和2-β-D-呋喃核糖基噻唑-5-甲酰胺(23)的前体。还描述了将2-β-D-呋喃核糖基噻唑-4-甲酰胺(12)结构修饰为2-(2,3,5-三-O-乙酰基-β-D-呋喃核糖基)噻唑-4-甲酰胺(15)、2-β-D-呋喃核糖基噻唑-4-硫代甲酰胺(17)和2-(5-脱氧-β-D-呋喃核糖基)噻唑-4-甲酰胺(19)的过程。对这些噻唑核苷进行了抗1型疱疹病毒、3型副流感病毒和13型鼻病毒的体外活性测试,并针对副流感病毒进行了体内实验。它们还被评估为嘌呤核苷酸生物合成的潜在抑制剂。结果表明,具有最显著抗病毒活性的化合物(12和15)也是鸟嘌呤核苷酸生物合成的活性抑制剂(40-70%)。